Neurocrine Biosciences Inc
General
Total Cases25
Active Cases3
Patents105
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
L4
C
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/15/25 | Summons Issued as to Spruce Biosciences, Inc. on 1/14/2025. (scs) (Entered: 01/15/2025) | |
| 01/15/25 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Neurocrine Biosciences, Inc. filed by Neurocrine Biosciences, Inc.. (scs) (Entered: 01/15/2025) | |
| 01/15/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,344,557 B2. (scs) (Entered: 01/15/2025) | |
| 01/15/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 01/15/2025) | |
| 01/15/25 | COMPLAINT against Spruce Biosciences, Inc. (Filing fee $ 405, receipt number ADEDC-4590478) - filed by Neurocrine Biosciences, Inc.. (Attachments: # [1] Exhibits A-Z, # [2] Civil Cover Sheet)(scs) (Entered: 01/15/2025) | |
| 11/15/24 | NOTICE OF SERVICE of Expert Opinion of Thomas Charles Dowling, Pharm.D, Ph.D; Expert Opinon of Ron H. Bihovsky; Expert Opinion of Jawad Amad M.D., F.R.C.P., F.A.A.S.I.D; and Expert Report of Ivan T. Hoffman filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc..(Grivner, Geoffrey) (Entered: 11/15/2024) | |
| 11/14/24 | NOTICE OF SERVICE of (1) Opening Expert Report of Stephen G. Davies, D.Phil., Regarding Infringement of U.S. Patent No. 11,542,239; (2) Opening Expert Report of James A. Simon, M.D., Regarding Infringement of U.S. Patent Nos. 7,419,983, 10,537,572, 10,682,351, 11,690,845, and 11,690,854; and (3) Opening Expert Report of David R. Taft, Ph.D., Regarding Infringement of U.S. Patent Nos. 10,537,572, 10,682,351, and 11,690,845 filed by AbbVie Inc., AbbVie Ltd., Neurocrine Biosciences, Inc..(Tigan, Jeremy) (Entered: 11/14/2024) | |
| 10/25/24 | SO ORDERED, re [277] Stipulation and Order Regarding Scope of 30(b)(6) Topics. Signed by Judge Jennifer L. Hall on 10/25/2024. (ceg) (Entered: 10/25/2024) | |
| 10/22/24 | STIPULATION and [Proposed] Order Regarding Scope of 30(b)(6) Topics by AbbVie Inc., AbbVie Ltd., Neurocrine Biosciences, Inc.. (Attachments: # [1] Ex. A, # [2] Ex. B, # [3] Ex. C)(Tigan, Jeremy) (Entered: 10/22/2024) | |
| 10/03/24 | NOTICE requesting Clerk to remove Constance Lee as co-counsel.. (Tigan, Jeremy) (Entered: 10/03/2024) |